Full Text (PDF)
Review Article

Sub Standard and Falsified Drugs Toxicity: An Alarming Concern of Today

Neha Jain

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Journal of Forensic Chemistry and Toxicology 12(1):p 21-24, Jan - June 2026. | DOI: 10.21088/jfct.2454.9363.12126.3

How Cite This Article:

Jain N. Sub Standard and Falsified Drugs Toxicity: An Alarming Concern of Today. J Forensic Chem Toxicol. 2026;12(1):21-24.

Timeline

Received : November 04, 2025         Accepted : December 27, 2025          Published : June 30, 2026

Abstract

The prevalence of Substandard and falsified medicines leads to severe toxic impact on the health of the general public especially in low and middle-income countries. Substandard and falsified medical products pose significant threats to public health globally showing inefficacy in treatment of illness, because of presence of incorrect ingredients or incorrect dosages. These drugs are not only showing direct harmful effects to patients being of falsified nature but also leads to fatality in children. These substandard drugs may be indirectly harmful through increased risk of antimicrobial resistance and thereby affecting every region of the world in today’s scenario resulted in loss of confidence in medicines, healthcare providers and health systems. The present article is aimed to create awareness regarding the toxicity of substandard and falsified drugs onto the public-health. This article also shed light on the types of formulation defects that can occur along with the consequences of consumption of substandard drugs. For the improvement of quality, there must an eye check onto the manufacturing practices in accordance with global accepted standards. The article also sheds light on some suggestive measures to cope up these wrong practices.


References

  • 1.   https://www.who.int/news/item/29-05- 2017-seventieth-world-health-assemblyupdate-29-may-2017.
  • 2.   Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol. 2014 Aug; 78(2):218-43. doi: 10.1111/bcp.12298. PMID: 24286459; PMCID: PMC4137817. 3. https://www.who.int/news-room/factsheets/detail/substandard-and-falsifiedmedical-products.
  • 4.   https://www.bbc.com/news/world-asiaindia-63226055.
  • 5.   h t t p s : / / w w w . n p r . o r g / s e c t i o n s / goatsandsoda/2023/08/31/1196893607/ whatever-happened-to-the-case-of-66-childdeaths-linked-to-cough-syrup-from-india.
  • 6.   https://timesofindia.indiatimes.com/ c i t y / b h o p a l / 2 - m o r e - s y r u p s - b a n n e d - a s - t e s t s - c o n f i r m - t o x i c - s u b s t a n c e / articleshow/124347784.cms.
  • 7.   Madhya Pradesh: 2 more syrups banned as tests confirm toxic substance; manufacturers face legal action | Bhopal News - The Times of India.
  • 8.   Death toll from contaminated cough syrup in Madhya Pradesh rises to 20 | The Independent.
  • 9.   Cough syrup deaths: 6-month-old girl dies after consuming Ayurvedic syrup in Chhindwara, shop sealed - India Today.
  • 10.   https://www.who.int/news/item/13- 10-2025-medical-product-alert-n-5-2025-- substandard-(contaminated)-oral-liquidmedicines.
  • 11.   Sammons HM, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatr Open. 2017 May 18;1(1):e000007. doi: 10.1136/ bmjpo-2017-000007. PMID: 29637090; PMCID: PMC5842987.
  • 12.   IFPMA. Pharmacovigilance of biotherapeutic medicines: Identifying global cases studies illustrating successes and challenges [Internet. Geneva: IFPMA; 2016 Jun [cited 2018 Oct 1].Available from: https://www.ifpma. org/wp-content/uploads/2016/06/2016- Pharmacovigilance-ofbiotherapeuticmedicines-Case-studies.pdf
  • 13.   Hauk C, Hagen N, Heide L. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries. Am J Trop Med Hyg. 2021 Mar 31;104(5):1936-1945. doi: 10.4269/ajtmh.20-1612. PMID: 33788775; PMCID: PMC8103440.
  • 14.   https://www.undrr.org/understandingdisaster-risk/terminology/hips/ch0602.

About this article


Cite this article

Jain N. Sub Standard and Falsified Drugs Toxicity: An Alarming Concern of Today. J Forensic Chem Toxicol. 2026;12(1):21-24.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Received Accepted Published
November 04, 2025 December 27, 2025 June 30, 2026

DOI: 10.21088/jfct.2454.9363.12126.3

Keywords

Substandard DrugsFalsified DrugsToxicityConsumptionQuality

Article Level Metrics

Last Updated

Tuesday 21 July 2026, 13:46:27 (IST)


884

Accesses

14
92
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received November 04, 2025
Accepted December 27, 2025
Published June 30, 2026

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Access this article



Share